Tracing the spread of Hepatitis C virus in Turkey: A phylogenetic analysis

Intervirology

Volumn 56, Issue 3, 2013, Pages 201-205

  Sunbul, Mustafa ^a   Khan, Anis ^b   Kurbanov, Fuat ^b   Leblebicioglu, Hakan ^a   Sugiyama, Masaya ^c   Tanaka, Yasuhito ^b   Mizokami, Masashi ^b,c  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

HCV genotypes; Molecular epidemiology; Phylogenetic analysis; Turkey

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; FETOPROTEIN; GLOBULIN; HEPATITIS B SURFACE ANTIGEN; NONSTRUCTURAL PROTEIN 5B; PROTEIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; CLUSTER ANALYSIS; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GLOBULIN BLOOD LEVEL; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS SUBTYPE 1B; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TURKEY (REPUBLIC); VIRUS GENOME; VIRUS STRAIN; VIRUS TRANSMISSION;

HEPATITIS C VIRUS;

EID: 84878015405     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000346775     Document Type: Article

References (20)

1. Chevaliez S, Pawlotsky JM. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 2007; 13: 2461-2466
2. Takada N, Takase S, Takada A, Date T. HCV genotypes in different countries. Lancet 1992; 339: 808
3. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-982
4. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C. a randomised trial. Lancet 2001; 358: 958-965
5. Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H Jr, Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM. Peginterferon-Alpha2a and ribavirin combination therapy in chronic hepatitis C. a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004; 140: 346-355
6. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321-1324
7. Nakano T, Lau GM, Sugiyama M, Mizokami M. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int 2012; 32: 339-345
8. Tanaka Y, Kurbanov F, Mano S, Orito E, Vargas V, Esteban JI, Yuen MF, Lai CL, Kramvis A, Kew MC, Smuts HE, Netesov SV, Alter HJ, Mizokami M. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology 2006; 130: 703-714
9. Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, Yunusova Z, Mizokami M. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol 2003; 69: 367-375
10. Ohno T, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, Mukaide M, Williams R, Lau JY. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997; 35: 201-207
11. Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, Alter HJ. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA 2002; 99: 15584-15589
12. Takeuchi T, Katsume A, Tanaka T, Abe A, Inoue K, Tsukiyama-Kohara K, Kawaguchi R, Tanaka S, Kohara M. Real-Time detection system for quantification of hepatitis C virus genome. Gastroenterology 1999; 116: 636-642
13. Shin IT, Tanaka Y, Tateno Y, Mizokami M. Development and public release of a comprehensive hepatitis virus database. Hepatol Res 2008; 38: 234-243
14. Huang JF, Dai CY, Lin YY, Yu ML, Liu SF, Lin IL, Hsieh MY, Lee LP, Lin ZY, Chen SC, Chang WY, Chuang WL. Performance characteristics of a real-Time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infections. Clin Chem Lab Med 2008; 46: 475-480
15. Hong SK, Cho SI, Ra EK, Kim EC, Park JS, Park SS, Seong MW. Evaluation of two hepatitis C virus genotyping assays based on the 5 ' untranslated region (UTR): The limitations of 5 ' UTR-based assays and the need for a supplementary sequencing-based approach. J Clin Microbiol 2012; 50: 3741-3743
16. McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med 2009; 361: 580-593
17. Magiorkinis G, Magiorkinis E, Paraskevis D, Ho SY, Shapiro B, Pybus OG, Allain JP, Hatzakis A. The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med 2009; 6: e1000198
18. Bruno S, Crosignani A, Maisonneuve P, Rossi S, Silini E, Mondelli MU. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology 2007; 46: 1350-1356
19. Tanaka Y, Agha S, Saudy N, Kurbanov F, Orito E, Kato T, Abo-Zeid M, Khalaf M, Miyakawa Y, Mizokami M. Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol 2004; 58: 191-195
20. Tanaka Y, Hanada K, Orito E, Akahane Y, Chayama K, Yoshizawa H, Kato T, Sata M, Ohta N, Miyakawa Y, Gojobori T, Mizokami M. Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C endemic of Japan. J Hepatol 2005; 42: 47-53